Search research articles
Contact Us
Filters
Showing results (31-40 of 51) with videos related to
Page
of 6
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 28, 2012
ALK-gene rearrangement: a comparative analysis on circulating tumour cells and tumour tissue from patients with lung adenocarcinoma
M Ilie, E Long, C Butori, et al.
British Journal of Cancer
|
January 30, 2014
Clinical value of circulating endothelial cells and of soluble CD146 levels in patients undergoing surgery for non-small cell lung cancer
M Ilie, E Long, V Hofman, et al.
Current Molecular Medicine
|
February 24, 2018
Immunotherapy in Non-Small Cell Lung Cancer: Biological Principles and Future Opportunities
M Ilie, J Benzaquen, V Hofman, et al.
British Journal of Cancer
|
May 13, 2010
High levels of carbonic anhydrase IX in tumour tissue and plasma are biomarkers of poor prognostic in patients with non-small cell lung cancer
M Ilie, N M Mazure, V Hofman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 24, 2018
Detection of PD-L1 in circulating tumor cells and white blood cells from patients with advanced non-small-cell lung cancer
M Ilié, E Szafer-Glusman, V Hofman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 26, 2014
Discrepancies between FISH and immunohistochemistry for assessment of the ALK status are associated with ALK 'borderline'-positive rearrangements or a high copy number: a potential major issue for anti-ALK therapeutic strategies
M I Ilie, C Bence, V Hofman, et al.
Oncogene
|
May 27, 2016
NF-kB2 induces senescence bypass in melanoma via a direct transcriptional activation of EZH2
G M De Donatis, E Le Pape, A Pierron, et al.
Oncogene
|
September 15, 2015
NF-kB2 induces senescence bypass in melanoma via a direct transcriptional activation of EZH2
G M De Donatis, E Le Pape, A Pierron, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
September 18, 2015
Why and how immunohistochemistry should now be used to screen for the BRAFV600E status in metastatic melanoma? The experience of a single institution (LCEP, Nice, France)
E Long, M Ilie, S Lassalle, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 8, 2012
Diagnostic value of immunohistochemistry for the detection of the BRAFV600E mutation in primary lung adenocarcinoma Caucasian patients
M Ilie, E Long, V Hofman, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 51) with videos related to
Sort By:
Page
of 6
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 28, 2012
ALK-gene rearrangement: a comparative analysis on circulating tumour cells and tumour tissue from patients with lung adenocarcinoma
M Ilie, E Long, C Butori, et al.
British Journal of Cancer
|
January 30, 2014
Clinical value of circulating endothelial cells and of soluble CD146 levels in patients undergoing surgery for non-small cell lung cancer
M Ilie, E Long, V Hofman, et al.
Current Molecular Medicine
|
February 24, 2018
Immunotherapy in Non-Small Cell Lung Cancer: Biological Principles and Future Opportunities
M Ilie, J Benzaquen, V Hofman, et al.
British Journal of Cancer
|
May 13, 2010
High levels of carbonic anhydrase IX in tumour tissue and plasma are biomarkers of poor prognostic in patients with non-small cell lung cancer
M Ilie, N M Mazure, V Hofman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 24, 2018
Detection of PD-L1 in circulating tumor cells and white blood cells from patients with advanced non-small-cell lung cancer
M Ilié, E Szafer-Glusman, V Hofman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 26, 2014
Discrepancies between FISH and immunohistochemistry for assessment of the ALK status are associated with ALK 'borderline'-positive rearrangements or a high copy number: a potential major issue for anti-ALK therapeutic strategies
M I Ilie, C Bence, V Hofman, et al.
Oncogene
|
May 27, 2016
NF-kB2 induces senescence bypass in melanoma via a direct transcriptional activation of EZH2
G M De Donatis, E Le Pape, A Pierron, et al.
Oncogene
|
September 15, 2015
NF-kB2 induces senescence bypass in melanoma via a direct transcriptional activation of EZH2
G M De Donatis, E Le Pape, A Pierron, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
September 18, 2015
Why and how immunohistochemistry should now be used to screen for the BRAFV600E status in metastatic melanoma? The experience of a single institution (LCEP, Nice, France)
E Long, M Ilie, S Lassalle, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 8, 2012
Diagnostic value of immunohistochemistry for the detection of the BRAFV600E mutation in primary lung adenocarcinoma Caucasian patients
M Ilie, E Long, V Hofman, et al.
Page
of 6